{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:23:34Z","timestamp":1760833414840,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.breast.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,3,20]],"date-time":"2016-03-20T06:45:22Z","timestamp":1458456322000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast Surgeons"],"prefix":"10.1016","volume":"27","author":[{"given":"C.","family":"Markopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Koukouras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Venizelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Karyda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Xepapadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Misitzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kalogerakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Poulakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Natsiopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Zobolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Savidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Antonopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tzoracoleftherakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2016.02.007_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","article-title":"Estimates of the cancer incidence and mortality in Europe in 2006","volume":"18","author":"Ferlay","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2016.02.007_bib2","unstructured":"IARC - International Agency For Research On Cancer; http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx."},{"issue":"20 Pt 2","key":"10.1016\/j.breast.2016.02.007_bib3","doi-asserted-by":"crossref","first-page":"6309s","DOI":"10.1158\/1078-0432.CCR-06-0652","article-title":"Skeletal complications of breast cancer therapies","volume":"15","author":"Hirbe","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"Suppl.\u00a0(2)","key":"10.1016\/j.breast.2016.02.007_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3816\/CBC.2005.s.006","article-title":"Strategies to prevent chemotherapy-induced bone loss in women with breast cancer","volume":"5","author":"Theriault","year":"2005","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2016.02.007_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ctrv.2005.01.008","article-title":"The causes and treatment of bone loss associated with carcinoma of the breast","volume":"31","author":"Lester","year":"2005","journal-title":"Cancer Treat Rev"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.breast.2016.02.007_bib6","doi-asserted-by":"crossref","first-page":"iii124","DOI":"10.1093\/annonc\/mdu103","article-title":"Bone health in cancer patients: ESMO clinical practice guidelines","volume":"25","author":"Coleman1","year":"2014","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.breast.2016.02.007_bib7","first-page":"229","article-title":"Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial","volume":"6","author":"Markopoulos","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2016.02.007_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0002-9343(03)00127-X","article-title":"The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer","volume":"114","author":"Greep","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.breast.2016.02.007_bib9","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","article-title":"Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer","volume":"19","author":"Shapiro","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.02.007_bib10","first-page":"S27","article-title":"Effect of anastrozole on bone mineral density: 2-year results of the 'arimidex' (anastrozole), tamoxifen, alone or in combination (ATAC) trial [Abstract 129]","volume":"83","author":"Howell","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2016.02.007_bib11","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1200\/jco.2005.23.16_suppl.533","article-title":"Zoledronic acid (ZA) effectively inhibits cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (Let): 12 mos BMD results of the Z-FAST trial [abstract 533]","volume":"23","author":"Brufsky","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"4 Suppl 1","key":"10.1016\/j.breast.2016.02.007_bib12","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.amjmed.2005.12.020","article-title":"Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?","volume":"119","author":"Bonnick","year":"2006","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.breast.2016.02.007_bib13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/02841860802001467","article-title":"Adverse bone effects during pharmacological breast cancer therapy","volume":"47","author":"Bjarnason","year":"2008","journal-title":"Acta Oncol"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.breast.2016.02.007_bib14","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.breast.2007.10.004","article-title":"Reducing the risk of bone loss associated with breast cancer treatment","volume":"16","author":"Hadji","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.breast.2016.02.007_bib15","first-page":"202","article-title":"An assessment of fracture rates over time (between 6 and 48 months) in the ATAC (Arimidex, tamoxifen, alone or in combination) trial","author":"Howell","year":"2003","journal-title":"Eur J Cancer"},{"issue":"24","key":"10.1016\/j.breast.2016.02.007_bib16","first-page":"559S","article-title":"Bone mineral density (bmd) changes at 1 year in postmenopausal women who are not receiving adjuvant endocrine therapy for breast cancer (BCA)","volume":"69","author":"Van Poznak","year":"2009","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.breast.2016.02.007_bib17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1359\/jbmr.060508","article-title":"Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)","volume":"21","author":"Eastell","year":"2006","journal-title":"J\u00a0Bone Min Res"},{"issue":"3","key":"10.1016\/j.breast.2016.02.007_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bone.2007.06.004","article-title":"Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates","volume":"41","author":"Confavreux","year":"2007","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.breast.2016.02.007_bib19","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ejca.2005.10.028","article-title":"Effects of third-generation aromatase inhibitors on bone","volume":"42","author":"McCloskey","year":"2006","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.breast.2016.02.007_bib20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.2012.44.7805","article-title":"Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27\u2013a randomized controlled phase III trial","volume":"31","author":"Goss","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.breast.2016.02.007_bib21","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00198-007-0439-4","article-title":"Management of cancer treatment-induced bone loss in early breast and prostate cancer \u2013 a consensus paper of the Belgian Bone Club","volume":"18","author":"Body","year":"2007","journal-title":"Osteoporos Int"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.breast.2016.02.007_bib22","first-page":"S1","article-title":"NCCN task force report: bone health in cancer care","volume":"7","author":"Gralow","year":"2009","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.breast.2016.02.007_bib23","first-page":"S1","article-title":"NCCN task force report: bone health in cancer care","volume":"11","author":"Gralow","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"20","key":"10.1016\/j.breast.2016.02.007_bib24","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa0810266","article-title":"Adjuvant chemotherapy in older women with early-stage breast cancer","volume":"360","author":"Muss","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2016.02.007_bib25","unstructured":"C. Markopoulos, D. Koukouras, G. Xepapadakis, V. Venizelos, E. Tzoracoleftherakis, J. Misitzis, et al. Age effect on treatment decision for adjuvant chemotherapy in women with ER-positive early breast cancer: analysis of the basic data of the POCHARBI trial, an observational study conducted by the Hellenic Society of Breast Surgeons. European Breast Cancer Conference, 2014 EBCC-9. March 19 \u2013 21, 2014 in Glasgow, Scotland, UK (available at: http:\/\/www.ecco-org.eu\/Events\/Past-conferences\/EBCC9\/Abstract-search?abstractid=10019)."},{"issue":"1","key":"10.1016\/j.breast.2016.02.007_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1634\/theoncologist.2012-0315","article-title":"Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis","volume":"18","author":"van de Water","year":"2013","journal-title":"Oncologist"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616000229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616000229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:33:53Z","timestamp":1760776433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977616000229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":26,"alternative-id":["S0960977616000229"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2016.02.007","relation":{},"ISSN":["0960-9776"],"issn-type":[{"type":"print","value":"0960-9776"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast Surgeons","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}